Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

May 25, 2024

Study Completion Date

May 25, 2024

Conditions
Candidiasis, Oral
Interventions
DRUG

Nitric Oxide

Nitric Oxide Releasing Mouthwash will be self-administered by the participant three times throughout the day for 21 days. The intervention solution will be poured into their mouth from a medication cup containing 20 mL of the solution. Total exposure to study intervention will be a maximum of 63 treatments totaling 1,260 mL. All participants will be monitored for 7 days post-last treatment dose (to Day 28).

Trial Locations (1)

V5Z 4T1

Atlantis Dental Cambie, Vancouver

All Listed Sponsors
lead

Sanotize Research and Development corp.

INDUSTRY

NCT06120816 - Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis | Biotech Hunter | Biotech Hunter